NEW YORK , Sept. 23, 2024 /PRNewswire/ -- MTS Health Partners ("MTS") announced today that healthcare investment banker Aaron Schwimmer has joined their global life sciences practice as a Partner based in New York . With over twenty years of healthcare investment banking experience, Schwimmer will continue serving as a trusted advisor to life sciences companies, focusing on expanding MTS's presence in the sector to help drive the firm's growth and increase its market share.
Schwimmer was most recently at Bank of America, where he represented a wide range of privately-held and publicly-traded companies across the life sciences sector. Over the course of his career, he has been involved in more than 50 completed transactions valued at hundreds of billions of dollars. "For more than two decades Aaron has earned the trust of life science leaders for his deep expertise in the industry and delivering for his clients," said Curtis Lane , Founding Partner of MTS.
"We are thrilled to welcome him to MTS at this pivotal and exciting time in the growth of our firm." "Aaron has invested his entire career in understanding what biotech companies need to achieve their goals on behalf of patients and society more broadly," said Andrew Weisenfeld , MTS Managing Partner. "His expertise and approach meaningfully expand our coverage of the life sciences sector and further cements our standing as a leader in healthcare investment banking.
" "MTS's exclusive focus on healthcare, provides clients wit.